(Q37762275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

review article

1 reference

title

Surface plasmon resonance for vaccine design and efficacy studies: recent applications and future trends (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

surface plasmon resonance

4 February 2020

main subject

1 reference

1 reference

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

B Vijayalakshmi Ayyar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

4

Barry Byrne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Stephen Hearty

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Richard O'Kennedy

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

1 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Vaccines

4 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

page(s)

645-664

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20518719%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

cites work

Spying on HIV with SPR.

1 reference

Structural characteristics correlate with immune responses induced by HIV envelope glycoprotein vaccines

21 January 2018

1 reference

Identifying epitopes of HIV-1 that induce protective antibodies

21 January 2018

1 reference

Viral sequence diversity: challenges for AIDS vaccine designs

21 January 2018

1 reference

HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

21 January 2018

1 reference

Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.

21 January 2018

1 reference

The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and Immunogens

21 January 2018

1 reference

HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells

21 January 2018

1 reference

A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies

21 January 2018

1 reference

Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize human immunodeficiency virus type 1 primary isolates from various clades.

21 January 2018

1 reference

Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization

21 January 2018

1 reference

Analysis of HIV-1 subtype B third variable region peptide motifs for induction of neutralizing antibodies against HIV-1 primary isolates

21 January 2018

1 reference

Mimicking the structure of the V3 epitope bound to HIV-1 neutralizing antibodies

21 January 2018

1 reference

Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro

21 January 2018

1 reference

Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes

21 January 2018

1 reference

A review of vaccine research and development: the human immunodeficiency virus (HIV).

21 January 2018

1 reference

HIV vaccine design and the neutralizing antibody problem

21 January 2018

1 reference

Restraining the conformation of HIV-1 gp120 by removing a flexible loop

21 January 2018

1 reference

Antibody 17b binding at the coreceptor site weakens the kinetics of the interaction of envelope glycoprotein gp120 with CD4.

21 January 2018

1 reference

Structural definition of a conserved neutralization epitope on HIV-1 gp120

21 January 2018

1 reference

Molecular features of the broadly neutralizing immunoglobulin G1 b12 required for recognition of human immunodeficiency virus type 1 gp120.

21 January 2018

1 reference

Characterization of the outer domain of the gp120 glycoprotein from human immunodeficiency virus type 1

21 January 2018

1 reference

Biochemical and biological characterization of a dodecameric CD4-Ig fusion protein: implications for therapeutic and vaccine strategies

21 January 2018

1 reference

Structure-based stabilization of HIV-1 gp120 enhances humoral immune responses to the induced co-receptor binding site

21 January 2018

1 reference

Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

21 January 2018

1 reference

The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design

21 January 2018

1 reference

Crystallographic Definition of the Epitope Promiscuity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5: Vaccine Design Implications

21 January 2018

1 reference

Human immunodeficiency virus type 1-neutralizing monoclonal antibody 2F5 is multispecific for sequences flanking the DKW core epitope

21 January 2018

1 reference

Fine definition of the epitope on the gp41 glycoprotein of human immunodeficiency virus type 1 for the neutralizing monoclonal antibody 2F5.

21 January 2018

1 reference

Enhancement of alpha -helicity in the HIV-1 inhibitory peptide DP178 leads to an increased affinity for human monoclonal antibody 2F5 but does not elicit neutralizing responses in vitro. Implications for vaccine design

21 January 2018

1 reference

Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein

21 January 2018

1 reference

Immunogenic presentation of a conserved gp41 epitope of human immunodeficiency virus type 1 on recombinant surface antigen of hepatitis B virus.

21 January 2018

1 reference

Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems

21 January 2018

1 reference

Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope

21 January 2018

1 reference

Solid-phase proteoliposomes containing human immunodeficiency virus envelope glycoproteins

21 January 2018

1 reference

Surface plasmon resonance for high-throughput ligand screening of membrane-bound proteins

21 January 2018

1 reference

Properties of nonfused liposomes immobilized on an L1 Biacore chip and their permeabilization by a eukaryotic pore-forming toxin

21 January 2018

1 reference

Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state

21 January 2018

1 reference

Role of HIV membrane in neutralization by two broadly neutralizing antibodies

21 January 2018

1 reference

The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes

21 January 2018

1 reference

Membrane association and epitope recognition by HIV-1 neutralizing anti-gp41 2F5 and 4E10 antibodies.

21 January 2018

1 reference

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

21 January 2018

1 reference

Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions

21 January 2018

1 reference

HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane

21 January 2018

1 reference

HIV-1 hides an Achilles' heel in virion lipids

21 January 2018

1 reference

Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface

21 January 2018

1 reference

Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41

21 January 2018

1 reference

Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation.

21 January 2018

1 reference

Kinetic dependence to HIV-1 entry inhibition

21 January 2018

1 reference

Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region

21 January 2018

1 reference

Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactions

21 January 2018

1 reference

The antigenic structure of the HIV gp120 envelope glycoprotein

21 January 2018

1 reference

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.

21 January 2018

1 reference

Antibody vs. HIV in a clash of evolutionary titans

21 January 2018

1 reference

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition

21 January 2018

1 reference

HIV-1 and influenza antibodies: seeing antigens in new ways

21 January 2018

1 reference

A peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120

21 January 2018

1 reference

Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope

21 January 2018

1 reference

Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.

21 January 2018

1 reference

Antigenic properties of peptide mimotopes of HIV-1-associated carbohydrate antigens.

21 January 2018

1 reference

Targeting carbohydrate antigens in HIV vaccine development

21 January 2018

1 reference

Multiple antigenic mimotopes of HIV carbohydrate antigens: relating structure and antigenicity.

21 January 2018

1 reference

Toward fully synthetic carbohydrate-based HIV antigen design: on the critical role of bivalency

21 January 2018

1 reference

Apical membrane antigen 1: a malaria vaccine candidate in review

21 January 2018

1 reference

The future for blood-stage vaccines against malaria

21 January 2018

1 reference

Vaccine-induced immunity to malaria parasites and the need for novel strategies

21 January 2018

1 reference

A review of human vaccine research and development: malaria

21 January 2018

1 reference

Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate

21 January 2018

1 reference

Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum

21 January 2018

1 reference

Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning

21 January 2018

1 reference

Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation

21 January 2018

1 reference

Structure of an IgNAR-AMA1 complex: targeting a conserved hydrophobic cleft broadens malarial strain recognition

21 January 2018

1 reference

Single-chain antibody fragment specific for Plasmodium vivax Duffy binding protein

21 January 2018

1 reference

Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle

21 January 2018

1 reference

Vaccine manufacturing: challenges and solutions

21 January 2018

1 reference

A novel assay for influenza virus quantification using surface plasmon resonance.

21 January 2018

1 reference

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

21 January 2018

1 reference

Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design

21 January 2018

1 reference

Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein

21 January 2018

1 reference

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

21 January 2018

1 reference

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

21 January 2018

1 reference

Non-immunized natural human heavy chain CDR3 repertoires allow the isolation of high affinity peptides mimicking a human influenza hemagglutinin epitope

21 January 2018

1 reference

Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus.

21 January 2018

1 reference

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants

21 January 2018

1 reference

Structure of severe acute respiratory syndrome coronavirus receptor-binding domain complexed with neutralizing antibody

21 January 2018

1 reference

Anti-idiotypic antibody as a potential candidate vaccine for Neisseria meningitidis serogroup B.

21 January 2018

1 reference

A future of cancer prevention and cures: highlights of the Centennial Meeting of the American Association for Cancer Research

21 January 2018

1 reference

Prophylactic HPV vaccines: new interventions for cancer control

21 January 2018

1 reference

Isolation and characterisation of a human anti-idiotypic scFv used as a surrogate tumour antigen to elicit an anti-HER-2/neu humoral response in mice

21 January 2018

1 reference

A llama single domain anti-idiotypic antibody mimicking HER2 as a vaccine: Immunogenicity and efficacy.

21 January 2018

1 reference

Synthetic peptide vaccine development: measurement of polyclonal antibody affinity and cross-reactivity using a new peptide capture and release system for surface plasmon resonance spectroscopy.

21 January 2018

1 reference

Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets

21 January 2018

1 reference

Exchanging murine and human immunoglobulin constant chains affects the kinetics and thermodynamics of antigen binding and chimeric antibody autoreactivity

21 January 2018

1 reference

Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab

21 January 2018

1 reference

Survey of the year 2006 commercial optical biosensor literature

21 January 2018

1 reference

Survey of the year 2005 commercial optical biosensor literature

21 January 2018

1 reference

Survey of the year 2003 commercial optical biosensor literature

21 January 2018

1 reference

Survey of the year 2004 commercial optical biosensor literature

21 January 2018

1 reference

Grading the commercial optical biosensor literature-Class of 2008: 'The Mighty Binders'.

21 January 2018

1 reference

Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines

21 January 2018

1 reference

An in vitro approach in quality control of toxoid vaccines.

21 January 2018

1 reference

Monitoring of influenza virus hemagglutinin in process samples using weak affinity ligands and surface plasmon resonance

21 January 2018

1 reference

Antibody production, design and use for biosensor-based applications

21 January 2018

1 reference

Kinetic screening of antibody-Im7 conjugates by capture on a colicin E7 DNase domain using optical biosensors

21 January 2018

1 reference

Biosensor technology: technology push versus market pull

21 January 2018

1 reference

Looking towards label-free biomolecular interaction analysis in a high-throughput format: a review of new surface plasmon resonance technologies

21 January 2018

1 reference

Determining kinetics and affinities of protein interactions using a parallel real-time label-free biosensor, the Octet

21 January 2018

1 reference

Exploring blocking assays using Octet, ProteOn, and Biacore biosensors

21 January 2018

1 reference

A global benchmark study using affinity-based biosensors.

21 January 2018

1 reference

Structural variation and immune recognition of the P1.2 subtype meningococcal antigen

21 January 2018

1 reference

Screening antibody–antigen interactions in parallel using Biacore A100

21 January 2018

1 reference